Clinical and economic evaluation of the trellis rhrombectomy device for arterial occlusions: Preliminary analysis

Journal of Vascular Surgery

Volumn 39, Issue 3, 2004, Pages 556-559

  Sarac, Timur P ^a   Hilleman, Daniel ^b   Arko, Frank R ^c   Zarins, Christopher K ^c   Ouriel, Kenneth ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; RETEPLASE; TENECTEPLASE;

AGED; ARTERY CATHETER; ARTERY OCCLUSION; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BYPASS SURGERY; CLINICAL ARTICLE; DEVICE; ECONOMIC EVALUATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SURVIVAL RATE; THROMBECTOMY;

EID: 1542316855     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2003.10.061     Document Type: Article

References (18)

1. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 1998;338:1105-11.
2. Ouriel K, Shortell CK, DeWeese JA, Green RM, Francis CW, Azodo MV, et al. A comparison of thrombolytic therapy with operative revascularization in the treatment of acute peripheral arterial ischemia. J Vasc Surg 1994;19:1021-30.
3. STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity: The STILE trial. Ann Surg 1994;220:251-68.
4. Ouriel K, Gray B, Clair DG, Olin J. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol 2000;11:295-8.
5. Korn P, Khilnani NM, Fellers JC, Lee TY, Winchester PA, Bush HL, et al. Thrombolysis for native arterial occlusions of the lower extremities: clinical outcome and cost. J Vasc Surg 2001;33:114-57.
6. Kasirajan K, Marek JM, Langsfeld M. Mechanical thrombectomy as a first-line treatment for arterial occlusion. Semin Vasc Surg 2001;14: 123-31.
7. Kasirajan K, Gray B, Beavers F, Clair DG, Greenberg R, Mascha E, et al. Rheolytic thrombectomy in the management of acute and subacute limb-threatening ischemia. J Vasc Interv Radiol 2001;12:413-21.
8. Ahn SS, Rutherford RB, Becker GJ, Comerota AJ, Johnston KW, McClean GK, et al. Reporting standards for lower extremity arterial endovascular procedures. J Vasc Surg 1993;17:1103-7.
9. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38.
10. Patel N, Sacks D, Patel RI, Moresco KP, Ouriel K, Gray R, et al. SCIVR reporting standards for the treatment of acute limb ischemia with the use of transluminal removal of arterial thrombus. J Vasc Interv Radiol 2001;12:559-70.
11. Kalish SC, Gurwitz JH, Krumholz HM, Avorn J. A cost-effectiveness model of thrombolytic therapy for acute myocardial infarction. J Gen Intern Med 1995;10:321-30.
12. Abel DB. Ongoing FDA evaluation of approved endografts. J Vasc Surg 2003;37:902-3.
13. Kasirajan K, Haskal Z, Ouriel K. The use of mechanical thrombectomy devices in the management of acute peripheral arterial occlusive disease. J Vasc Interv Radiol 2001;12:405-11.
14. Cohen DJ, Ramee S, Baim DS, Sharma S, Carrozza JP, Cosgrove R, et al. Economic assessment of rheolytic thrombectomy versus intracoronary urokinase for treatment of extensive intracoronary thrombus: results from a randomized clinical trial. Am Heart J 2001;142:648-56.
15. Hoch JR, Tullis MJ, Acher CW, Heisy DM, Crummy AB, McDermott JC, et al. Thrombolysis vs surgery as the initial management for native artery occlusion: efficacy, safety, and cost. Surgery 1994;116:649-57.
16. Bosch JL, Haaring C, Meyerovitz MF, Cullen KA, Hunink MGM. Cost-effectiveness of percutaneous treatment of iliac artery occlusive disease in the United States. AJR 2000;175:517-21.
17. Bosch JL, Tetteroo E, Mali W, Hunink MGM. Iliac arterial occlusive disease: cost effectiveness analysis of stent placement versus percutaneous transluminal angioplasty. Radiology 1998;208:641-8.
18. Hoch JR, Tullis MJ, Acher CW, Heisy DM, Crummy AB, McDermott JC, et al. Thrombolysis vs surgery as the initial management for native artery occlusion: efficacy, safety, and cost. Surgery 1994;116:649-57.